David Harel, Co-Founder and Chief Executive Officer of CytoReason, is a well-rounded business leader with proven strategic thinking and demonstrated execution in healthcare, technology, and finance. He spent the first part of his career in private equity, focusing on strategy and financing of growth companies in industrial and healthcare IT markets. Prior to CytoReason, David served as the CEO of Virtual OfficeWare Healthcare Solutions. He is an expert at evaluating business models, creating targeted go-to-market plans, and focusing on the right opportunities. David has excellent negotiation skills with demonstrated capacity to close large contracts. David also has direct experience in P&L management, M&A, market evaluation, sales planning, and financial analysis.